These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2207197)

  • 21. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
    Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
    Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4.
    Zhang T; Somasundaram R; Berencsi K; Caputo L; Gimotty P; Rani P; Guerry D; Swoboda R; Herlyn D
    Eur J Immunol; 2006 Feb; 36(2):457-67. PubMed ID: 16421945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell precursor frequency differentially affects CTL responses under different immune conditions.
    Ye Z; Ahmed KA; Huang J; Xie Y; Munegowda MA; Xiang J
    Biochem Biophys Res Commun; 2008 Mar; 367(2):427-34. PubMed ID: 18178159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bifurcation analysis of a mathematical model of the interaction of cytotoxic lymphocytes with tumor cells. The effect of immunologic amplification of tumor growth and its interconnection with other "anomolous" phenomena of oncoimmunology].
    Kuznetsov VA; Makalkin IA
    Biofizika; 1992; 37(6):1063-70. PubMed ID: 1298347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
    Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction.
    Asselin-Paturel C; Megherat S; Vergnon I; Echchakir H; Dorothée G; Blesson S; Gay F; Mami-Chouaib F; Chouaib S
    Cancer; 2001 Jan; 91(1):113-22. PubMed ID: 11148567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-kit+ FcR+ myelocytes are increased in cancer and prevent the proliferation of fully cytolytic T cells in the presence of immune serum.
    Beck C; Schreiber K; Schreiber H; Rowley DA
    Eur J Immunol; 2003 Jan; 33(1):19-28. PubMed ID: 12594828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy.
    Chamoto K; Wakita D; Narita Y; Zhang Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
    Cancer Res; 2006 Feb; 66(3):1809-17. PubMed ID: 16452242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Basic and clinical study of adoptive immunotherapy using cytotoxic T lymphocyte (CTL) against cancers].
    Kitsukawa K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1448-54. PubMed ID: 2543306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
    J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
    Jiang S; Persechini PM; Perussia B; Young JD
    J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatiotemporal effects of a possible chemorepulsion of tumor cells by immune system effectors.
    d'Onofrio A
    J Theor Biol; 2012 Mar; 296():41-8. PubMed ID: 22119911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An introduction to lymphocyte and viral dynamics: the power and limitations of mathematical analysis.
    Asquith B; Bangham CR
    Proc Biol Sci; 2003 Aug; 270(1525):1651-7. PubMed ID: 12964991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aging, immunity, and tumor susceptibility.
    Zhang HG; Grizzle WE
    Immunol Allergy Clin North Am; 2003 Feb; 23(1):83-102, vi. PubMed ID: 12645880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Watching the Internal Clock of Cells while They Move and Divide.
    Hughes BD
    Biophys J; 2018 Mar; 114(5):1007-1008. PubMed ID: 29539388
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of cell migration on the stability of immunogenic multicentric tumors].
    Alekseeva EI; Kuznetsov VA
    Biofizika; 1990; 35(3):509-12. PubMed ID: 2207197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Computer analysis of the dynamics of two tumor foci with respect to circulating immune cells].
    Kuznetsov VA; Alekseeva EI
    Biofizika; 1991; 36(1):109-13. PubMed ID: 1854819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL.
    Matsui S; Ahlers JD; Vortmeyer AO; Terabe M; Tsukui T; Carbone DP; Liotta LA; Berzofsky JA
    J Immunol; 1999 Jul; 163(1):184-93. PubMed ID: 10384115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.